These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 2389942

  • 1. [Antitumor activity of a novel analog of cytarabine, 4-amino-1-beta-D-arabinofuranosyl-2(1H)-pyrimidinone 5'-(sodium octadecyl phosphate) monohydrate (YNK01)].
    Nagahata T, Shibasaki C, Ishii T, Uchida T, Arakawa M, Kusama K, Ekimoto H, Takahashi K.
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 1):1437-45. PubMed ID: 2389942
    [Abstract] [Full Text] [Related]

  • 2. [Experimental combination chemotherapy of YNK01, a novel analog of cytarabine, with other antitumor agents].
    Uchida T, Nagahata T, Arakawa M, Ekimoto H, Takahashi K.
    Gan To Kagaku Ryoho; 1990 Jul; 17(7):1351-6. PubMed ID: 2114829
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Formulation, stability, and antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugate of thioether phospholipid.
    Hong CI, Bernacki RJ, Hui SW, Rustum Y, West CR.
    Cancer Res; 1990 Jul 15; 50(14):4401-6. PubMed ID: 2364392
    [Abstract] [Full Text] [Related]

  • 5. [Phase I study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate)].
    Fukuoka M, Miyazaki T, Yoshida Y, Hattori M, Niitani H, Nakamura T, Hirota Y, Ohta K, Tanaka M, Suzuoki Y.
    Gan To Kagaku Ryoho; 1990 Nov 15; 17(11):2213-9. PubMed ID: 2241185
    [Abstract] [Full Text] [Related]

  • 6. Antitumor activity of 1-beta-D-arabinofuranosylcytosine conjugated with polyglutamic acid and its derivative.
    Kato Y, Saito M, Fukushima H, Takeda Y, Hara T.
    Cancer Res; 1984 Jan 15; 44(1):25-30. PubMed ID: 6197162
    [Abstract] [Full Text] [Related]

  • 7. Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine.
    Ueda T, Kamiya K, Urasaki Y, Wataya S, Kawai Y, Tsutani H, Sugiyama M, Nakamura T.
    Cancer Res; 1994 Jan 01; 54(1):109-13. PubMed ID: 8261429
    [Abstract] [Full Text] [Related]

  • 8. Antitumor effects and pharmacology of orally administered N4-palmitoyl-1-beta-D-arabinofuranosylcytosine in mice.
    Hori K, Tsuruo T, Naganuma K, Tsukagoshi S, Sakurai Y.
    Cancer Res; 1984 Jan 01; 44(1):172-7. PubMed ID: 6690034
    [Abstract] [Full Text] [Related]

  • 9. [A new antileukemic drug, cytarabine ocfosfate].
    Tsukagoshi S.
    Gan To Kagaku Ryoho; 1993 Sep 01; 20(12):1877-83. PubMed ID: 8379682
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inhibition of tumor cell growth in vitro and in vivo by 1-beta-D-arabinofuranosylcytosine entrapped within phospholipid vesicles.
    Mayhew E, Papahadjopoulos D, Rustum YM, Dave C.
    Cancer Res; 1976 Dec 01; 36(12):4406-11. PubMed ID: 187321
    [Abstract] [Full Text] [Related]

  • 15. Pharmacokinetics of Ara-CMP-Stearate (YNK01): phase I study of the oral Ara-C derivative.
    Schleyer E, Braess J, Ramsauer B, Unterhalt M, Kaufmann C, Wilde S, Schüssler M, Hiddemann W.
    Leukemia; 1995 Jun 01; 9(6):1085-90. PubMed ID: 7596174
    [Abstract] [Full Text] [Related]

  • 16. 1-beta-D-arabinofuranosylcytosine conjugates of thioether phospholipids as a new class of potential antitumor drugs.
    Hong CI, Kirisits AJ, Buchheit DJ, Nechaev A, West CR.
    Cancer Drug Deliv; 1986 Jun 01; 3(2):101-13. PubMed ID: 3708534
    [Abstract] [Full Text] [Related]

  • 17. [Phase II study of YNK01 (1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate) on hematological malignancies].
    Tatsumi N, Yamada K, Ohshima T, Nakamura T, Ohno R, Masaoka T, Kimura I, Kimura K.
    Gan To Kagaku Ryoho; 1990 Dec 01; 17(12):2387-95. PubMed ID: 2260876
    [Abstract] [Full Text] [Related]

  • 18. [Antitumor effects of Behenoyl-ara-C (BH-AC) in combination with Idarubicin (IDA) in P 388 leukemic cell bearing mice].
    Watanabe A, Kuriyama H, Kiyota T.
    Gan To Kagaku Ryoho; 1996 Feb 01; 23(3):291-6. PubMed ID: 8712821
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Antitumor activity of 2'-deoxy-2'-methylidenecytidine, a new 2'-deoxycytidine derivative.
    Yamagami K, Fujii A, Arita M, Okumoto T, Sakata S, Matsuda A, Ueda T, Sasaki T.
    Cancer Res; 1991 May 01; 51(9):2319-23. PubMed ID: 2015596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.